SELLAS Life Sciences Group, Inc.

SLS ·Healthcare, Drug Manufacturers - General, United States

SEC Filings

Form	Filed	Description
8-K	Dec 14, 2020	FORM 8-K
8-K	Dec 10, 2020	FORM 8-K
8-K	Nov 13, 2020	8-K
10-Q	Nov 13, 2020	10-Q
SC 13G	Sep 21, 2020
D	Aug 31, 2020
SC 13G	Aug 25, 2020	SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP
EFFECT	Aug 24, 2020
UPLOAD	Aug 21, 2020
CORRESP	Aug 21, 2020
S-3	Aug 14, 2020	FORM S-3
8-K	Aug 13, 2020	8-K
10-Q	Aug 13, 2020	10-Q
8-K	Aug 4, 2020	FORM 8-K
EFFECT	Jun 11, 2020
424B3	Jun 11, 2020	424B3
8-K	Jun 11, 2020	FORM 8-K
CORRESP	Jun 9, 2020
UPLOAD	Jun 5, 2020
DEFA14A	Jun 3, 2020	DEFA14A
S-1	May 29, 2020	FORM S-1
8-K	May 14, 2020	8-K
10-Q	May 14, 2020	10-Q
DEFA14A	Apr 24, 2020	DEFA14A
DEF 14A	Apr 23, 2020	DEF 14A

← Newer Page 11 of 51 · 1272 filings Older →